Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
GEVA - As of  09/16/14, 09:27:19 PM:   139 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$65.39  Avg Vol(3m): 285,891  P/E: 0.00  EPS: -4.02

Email this page to a friend.    Institutional Transactions for GEVA

                Buy: Blue    Sell: Red
Non-meaningful transactions (gifts, grants, etc.) are automatically filtered out for quicker actions.
Buy(P) /
Sell(S)
P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
S 2014-09-02 2014-09-04 17:21:42 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 300 $72.88 $21,864.00 25,595 view
S 2014-09-02 2014-09-04 17:21:42 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 700 $71.96 $50,372.00 25,895 view
S 2014-09-02 2014-09-04 17:21:42 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 400 $70.50 $28,200.00 26,595 view
S 2014-09-02 2014-09-04 17:21:42 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 8,600 $69.88 $600,968.00 26,995 view
S 2014-06-25 2014-06-26 16:21:50 SYNAGEVA BIOPHARMA CORP GEVA Williams Glen (SVP, Technical Operations) 700 $108.02 $75,614.00 266 32.99% view
S 2014-06-12 2014-06-16 18:56:44 SYNAGEVA BIOPHARMA CORP GEVA Quart Barry D 1,000 $83.31 $83,310.00 0 4.74% view
S 2014-05-16 2014-05-20 16:42:52 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 200 $83.46 $16,692.00 0 -5.52% view
S 2014-05-16 2014-05-20 16:42:52 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 1,591 $82.71 $131,592.00 200 -6.48% view
S 2014-05-16 2014-05-20 16:42:52 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 8,136 $81.75 $665,118.00 1,791 -7.73% view
S 2014-04-01 2014-04-03 17:56:41 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 1,050 $85.76 $90,048.00 15,524 -5.80% view
S 2014-04-01 2014-04-03 17:56:41 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 4,746 $84.72 $402,081.00 16,574 -7.09% view
S 2014-04-01 2014-04-03 17:56:41 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 3,529 $83.50 $294,672.00 21,320 -8.66% view
S 2014-04-01 2014-04-03 17:56:41 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (EVP, CMO & Head of R&D) 10,675 $82.80 $883,890.00 24,849 -9.58% view
S 2014-03-12 2014-03-14 16:07:55 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Group Vice President, Finance) 3,037 $99.08 $300,906.00 192 20.57% view
S 2014-03-12 2014-03-14 16:07:55 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Group Vice President, Finance) 3,933 $98.49 $387,361.00 3,229 20.09% view
S 2014-03-12 2014-03-14 16:07:55 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Group Vice President, Finance) 700 $96.75 $67,725.00 7,162 18.66% view
P 2014-03-06 2014-03-07 17:55:16 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 9,031 $105.75 $955,028.00 211,614 -30.82% view
P 2014-03-06 2014-03-07 17:55:16 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 365,969 $105.75 $3.87012E7 8,172,520 -30.82% view
S 2014-02-18 2014-02-20 16:14:40 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 894 $104.22 $93,172.70 0 2.92% view
S 2014-02-18 2014-02-20 16:14:40 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 1,745 $103.05 $179,822.00 894 1.81% view
S 2014-02-18 2014-02-20 16:14:40 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 3,207 $102.18 $327,691.00 2,639 0.98% view
S 2014-02-18 2014-02-20 16:14:40 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 3,081 $101.14 $311,612.00 5,846 -0.04% view
S 2014-02-18 2014-02-20 16:14:40 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 1,000 $100.07 $100,070.00 8,927 -1.11% view
S 2014-01-29 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 400 $91.58 $36,632.00 1,031 -25.21% view
S 2014-01-29 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 1,502 $90.85 $136,457.00 1,431 -26.22% view
S 2014-01-29 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 5,600 $89.27 $499,912.00 2,933 -28.45% view
S 2014-01-29 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 18,652 $88.31 $1,647,160.00 8,533 -29.85% view
S 2014-01-29 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 24,817 $87.19 $2,163,790.00 27,185 -31.52% view
S 2014-01-28 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 812 $90.10 $73,161.20 1,031 -27.27% view
S 2014-01-28 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 8,402 $88.95 $747,358.00 1,843 -28.92% view
S 2014-01-28 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 32,609 $88.38 $2,881,980.00 10,245 -29.75% view
S 2014-01-28 2014-01-30 17:42:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 9,506 $87.16 $828,543.00 42,854 -31.56% view
S 2013-12-03 2013-12-04 17:07:55 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 413 $61.02 $25,201.30 267 -8.37% view
S 2013-12-03 2013-12-04 17:07:55 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 6,587 $60.49 $398,448.00 680 -9.32% view
S 2013-11-18 2013-11-20 16:56:41 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 500 $57.20 $28,600.00 0 -15.07% view
S 2013-11-18 2013-11-20 16:56:41 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 3,801 $55.99 $212,818.00 500 -17.56% view
S 2013-11-18 2013-11-20 16:56:41 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 1,765 $54.97 $97,022.00 4,301 -19.74% view
S 2013-11-18 2013-11-20 16:56:41 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 3,861 $53.98 $208,417.00 6,066 -21.93% view
S 2013-11-01 2013-11-04 17:35:42 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 100 $51.04 $5,104.00 267 -18.36% view
S 2013-11-01 2013-11-04 17:35:42 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 3,205 $50.34 $161,340.00 367 -20.00% view
S 2013-11-01 2013-11-04 17:35:42 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 3,695 $49.61 $183,309.00 3,572 -21.77% view
S 2013-10-01 2013-10-03 16:07:55 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 3,770 $64.61 $243,580.00 267 22.94% view
S 2013-10-01 2013-10-03 16:07:55 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 3,230 $63.97 $206,623.00 4,037 22.17% view
P* 2013-09-25 2013-09-27 16:09:44 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 25,663 $56.63 $1,453,300.00 202,583 4.86% view
P* 2013-09-25 2013-09-27 16:09:44 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 1,024,340 $56.63 $5.80082E7 7,806,550 4.86% view
P* 2013-09-25 2013-09-27 16:09:40 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 25,663 $56.63 $1,453,300.00 202,583 4.86% view
P* 2013-09-25 2013-09-27 16:09:40 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 1,024,340 $56.63 $5.80082E7 7,806,550 4.86% view
S 2013-08-21 2013-08-22 17:28:46 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 6,681 $47.19 $315,276.00 0 -12.61% view
S 2013-08-20 2013-08-22 17:28:46 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 7,800 $47.04 $366,912.00 0 -12.97% view
S 2013-08-16 2013-08-20 17:35:43 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 4,300 $47.47 $204,121.00 0 -8.76% view
S 2013-07-29 2013-07-29 18:35:52 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 15,895 $47.39 $753,264.00 1,031 0.61% view
S 2013-07-26 2013-07-29 18:35:52 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 17,204 $48.31 $831,125.00 1,031 3.04% view
S 2013-07-26 2013-07-29 18:35:52 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 52,190 $47.91 $2,500,420.00 18,235 2.23% view
S 2013-07-25 2013-07-29 18:35:52 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 14,711 $48.73 $716,867.00 18,235 3.34% view
S 2013-07-16 2013-07-17 16:21:51 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,029 $48.26 $97,919.50 0 4.35% view
S 2013-07-15 2013-07-17 16:21:51 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 495 $49.15 $24,329.20 2,029 1.51% view
S 2013-07-11 2013-07-15 16:35:49 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 13,237 $47.06 $622,933.00 0 -4.55% view
S 2013-06-12 2013-06-13 17:28:54 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 40,352 $40.48 $1,633,450.00 1,031 -16.48% view
S 2013-06-11 2013-06-13 17:28:54 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 29,648 $40.89 $1,212,310.00 1,031 -14.99% view
S 2013-04-08 2013-04-09 16:21:51 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 21,695 $49.49 $1,073,690.00 1,031 1.84% view
S 2013-04-05 2013-04-09 16:21:51 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 9,910 $50.11 $496,590.00 1,031 5.05% view
S 2013-04-01 2013-04-03 10:21:48 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 619 $54.92 $33,995.50 0 14.22% view
S 2013-04-01 2013-04-03 10:21:48 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) 3,797 $54.21 $205,835.00 619 13.10% view
S 2013-03-01 2013-03-06 08:00:04 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 1,713 $51.35 $87,962.50 0 -4.81% view
S 2013-03-01 2013-03-06 08:00:04 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 2,704 $50.39 $136,255.00 1,713 -6.81% view
S 2013-02-21 2013-02-22 17:06:34 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 45,392 $49.02 $2,225,120.00 1,031 -8.28% view
S 2013-02-20 2013-02-22 17:06:34 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 5,954 $49.60 $295,318.00 1,031 -6.03% view
S 2013-02-20 2013-02-22 17:06:34 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 18,654 $49.49 $923,186.00 6,985 -6.26% view
S 2013-02-01 2013-02-05 17:36:36 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 2,660 $48.02 $127,733.00 0 -7.66% view
S 2013-02-01 2013-02-05 17:36:36 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 1,757 $47.33 $83,158.80 2,660 -9.23% view
S 2013-01-18 2013-01-23 17:06:08 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 9,447 $50.08 $473,106.00 15,035 -2.66% view
S 2013-01-17 2013-01-18 17:00:50 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 200 $50.00 $10,000.00 15,035 -2.82% view
S 2013-01-16 2013-01-18 17:00:50 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 5,353 $50.07 $268,025.00 15,035 -2.68% view
S 2013-01-16 2013-01-18 16:50:56 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 9,927 $49.12 $487,614.00 0 -4.66% view
P 2013-01-09 2013-01-15 17:48:45 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J director 21,039 $47.53 $999,984.00 373,560 1.45% view
P 2013-01-04 2013-01-08 17:42:31 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 20,099 $47.53 $955,306.00 176,920 1.66% view
P 2013-01-04 2013-01-08 17:42:31 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 839,621 $47.53 $3.99072E7 6,782,220 1.66% view
P 2013-01-04 2013-01-08 17:41:11 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 20,099 $47.53 $955,306.00 176,920 1.66% view
P 2013-01-04 2013-01-08 17:41:11 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 839,621 $47.53 $3.99072E7 6,782,220 1.66% view
S 2013-01-02 2013-01-04 16:30:59 SYNAGEVA BIOPHARMA CORP GEVA Goldberg Mark Alan (SVP, Product Development) 4,417 $47.52 $209,896.00 0 -0.99% view
S 2012-12-19 2012-12-21 15:45:40 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 1,605 $46.07 $73,942.40 0 -10.55% view
S 2012-12-19 2012-12-21 15:45:40 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,395 $45.83 $109,763.00 1,605 -11.13% view
S 2012-12-17 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 1,600 $47.53 $76,048.00 1,031 -4.92% view
S 2012-12-17 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 23,715 $47.03 $1,115,320.00 2,631 -6.04% view
S 2012-12-17 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 7,004 $45.97 $321,974.00 26,346 -8.48% view
S 2012-12-14 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 13,281 $45.30 $601,629.00 1,031 -8.23% view
S 2012-12-13 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 2,701 $47.07 $127,136.00 1,031 -3.93% view
S 2012-12-13 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 3,300 $45.87 $151,371.00 3,732 -6.65% view
S 2012-12-13 2012-12-17 19:15:45 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 8,399 $45.12 $378,963.00 7,032 -8.42% view
S 2012-12-05 2012-12-06 17:06:13 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 12,000 $48.10 $577,255.00 1,031 1.19% view
S 2012-12-04 2012-12-06 17:06:13 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 23,000 $49.34 $1,134,850.00 1,031 3.67% view
S 2012-12-03 2012-12-04 17:21:04 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 30,000 $49.42 $1,482,490.00 1,031 3.82% view
S 2012-11-30 2012-12-04 17:21:04 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 5,000 $48.87 $244,326.00 1,031 5.25% view
S 2012-10-17 2012-10-19 17:10:49 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,000 $49.67 $99,340.00 0 2.54% view
S 2012-10-17 2012-10-19 17:10:49 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 2,000 $49.64 $99,280.00 2,000 2.48% view
S 2012-10-16 2012-10-18 17:40:55 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 900 $51.17 $46,053.00 0 5.39% view
S 2012-10-16 2012-10-18 17:40:55 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 1,900 $50.58 $96,102.00 900 4.29% view
S 2012-10-16 2012-10-18 17:40:55 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 7,127 $49.88 $355,495.00 2,800 2.95% view
S 2012-09-04 2012-09-06 17:00:46 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 300 $49.52 $14,856.00 0 -16.24% view
S 2012-09-04 2012-09-06 17:00:46 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 700 $48.92 $34,244.00 300 -17.66% view
S 2012-09-04 2012-09-05 17:30:57 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 54,813 $49.36 $2,705,370.00 1,031 -16.62% view
S 2012-08-31 2012-09-05 17:30:57 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 15,187 $49.88 $757,518.00 1,031 -7.12% view
S 2012-07-18 2012-07-20 17:45:47 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 6,618 $48.82 $323,091.00 0 -1.95% view
P 2012-07-13 2012-07-13 18:59:58 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 21,082 $41.20 $868,578.00 156,821 18.93% view
P 2012-07-13 2012-07-13 18:59:58 SYNAGEVA BIOPHARMA CORP GEVA 14159, L.P. various various various various various various d 864,918 $41.20 $3.56346E7 5,942,590 18.93% view
P 2012-07-13 2012-07-13 18:48:26 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 21,082 $41.20 $868,578.00 156,821 18.93% view
P 2012-07-13 2012-07-13 18:48:26 SYNAGEVA BIOPHARMA CORP GEVA BAKER FELIX director 10% owner 864,918 $41.20 $3.56346E7 5,942,590 18.93% view
P 2012-07-12 2012-07-13 16:20:11 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J director 36,500 $41.20 $1,503,800.00 352,521 19.54% view
P 2012-07-12 2012-07-13 16:20:11 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J director 36,500 $41.20 $1,503,800.00 378,435 19.54% view
S 2012-07-12 2012-07-13 14:33:51 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 29,200 $46.75 $1,365,100.00 186,357 -5.35% view
S 2012-06-27 2012-06-28 18:01:49 SYNAGEVA BIOPHARMA CORP GEVA AKKARAJU SRINIVAS other 313,451 $39.70 $1.2444E7 1,026,830 -26.42% view
S 2012-06-26 2012-06-28 18:01:49 SYNAGEVA BIOPHARMA CORP GEVA AKKARAJU SRINIVAS other 28,827 $40.16 $1,157,660.00 1,340,280 -24.43% view
S 2012-06-25 2012-06-27 17:25:49 SYNAGEVA BIOPHARMA CORP GEVA Quinn Anthony (SVP, Chief Medical Officer) 26,000 $40.65 $1,056,870.00 20,035 -20.40% view
S 2012-06-04 2012-06-05 17:10:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 20,866 $34.69 $723,785.00 1,031 -19.35% view
S 2012-06-01 2012-06-05 17:10:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 9,234 $35.96 $332,087.00 1,031 -12.78% view
S 2012-06-01 2012-06-05 17:10:48 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 19,900 $35.70 $710,446.00 10,265 -13.61% view
S 2012-06-01 2012-06-05 17:10:38 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 200 $36.44 $7,287.00 0 -11.32% view
S 2012-06-01 2012-06-05 17:10:38 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris (Vice President, Finance) 800 $35.56 $28,446.00 200 -14.07% view
S 2012-05-16 2012-05-18 16:45:59 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 11,572 $38.82 $449,225.00 0 2.06% view
S 2012-05-16 2012-05-18 16:45:59 SYNAGEVA BIOPHARMA CORP GEVA BOESS CARSTEN (SVP, Chief Financial Officer) 28,137 $38.16 $1,073,710.00 11,572 0.37% view
S 2012-04-23 2012-04-23 16:05:02 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 3,000 $40.10 $120,300.00 44,750 3.29% view
S 2012-04-20 2012-04-23 16:05:02 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 10,000 $39.66 $396,600.00 47,750 2.17% view
S 2012-03-23 2012-03-27 17:31:04 SYNAGEVA BIOPHARMA CORP GEVA Patel Sanj K (President & CEO) 50,000 $33.53 $1,676,410.00 1,031 -14.80% view
S 2012-02-29 2012-03-09 08:39:18 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 1,512 $39.19 $59,255.30 57,750 9.67% view
S 2012-02-29 2012-03-09 08:39:18 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 3,488 $39.19 $136,695.00 167,912 9.67% view
S 2012-02-22 2012-03-09 08:39:18 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 2,118 $38.90 $82,390.20 171,400 12.72% view
S 2012-02-21 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 942 $38.90 $36,643.80 173,518 11.54% view
S 2012-02-17 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 9,190 $38.50 $353,815.00 174,460 13.77% view
S 2012-02-16 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 15,750 $38.01 $598,658.00 183,650 12.65% view
S 2012-02-15 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 24,481 $37.34 $914,121.00 199,400 11.44% view
S 2012-02-13 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 61,262 $36.20 $2,217,680.00 235,557 9.78% view
S 2012-02-10 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 582 $35.70 $20,777.40 296,819 7.14% view
S 2012-02-07 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 884 $35.50 $31,382.00 297,401 6.11% view
S 2012-02-06 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 5,716 $35.62 $203,604.00 298,285 5.87% view
S 2012-02-02 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 100 $35.50 $3,550.00 304,001 0.45% view
S 2012-02-01 2012-03-09 08:37:38 SYNAGEVA BIOPHARMA CORP GEVA TISCH DANIEL R 10% owner 9,975 $35.50 $354,112.00 304,101 0.48% view
S 2012-02-27 2012-02-29 09:28:30 SYNAGEVA BIOPHARMA CORP GEVA Heberlig Chris officer (Vice President, Finance) 4,500 $36.88 $165,960.00 0 0.68% view
P 2012-01-10 2012-01-17 15:45:32 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J 10% owner 120,000 $25.18 $3,021,600.00 341,935 41.86% view
P 2012-01-10 2012-01-11 10:45:58 SYNAGEVA BIOPHARMA CORP GEVA TISCH THOMAS J 10% owner 1,200,000 $25.18 $3.0216E7 341,935 41.86% view
* An * after P or S in the Buy/Sell column means the transaction was filed by the insider as open market, but it was marked as private transaction by insidercow's proprietary method
Enter Another Stock Symbol: